Articles

Results 1 to 5 of 48
Most popular |Most recent


The FTC Sues Endo and Impax Over Opana ER Agreement . . . Again

USA - January 28 2021 Stop me if you’ve heard this one before: the FTC is suing pharmaceutical manufacturers Endo and Impax over an alleged “reverse payment” agreement to…

Amy N. Vegari, Jake Walter-Warner.

Major Development in BCBS Association Antitrust Litigation

USA - December 22 2020 Antitrust litigation has been ongoing for several years in the U.S. District Court for the Northern District of Alabama against one of the biggest…

Jake Walter-Warner, Melissa R. Ginsberg.

For the First Time Since TC Heartland, the Federal Circuit Addresses Venue in an ANDA Case the Holding May Also Impact BPCIA Litigation

USA - November 19 2020 On November 5, 2020, in Valeant Pharms. N. Am. LLC v. Mylan Pharms. Inc., No. 2019-2402, the Federal Circuit held that venue in Hatch-Waxman cases…

Andrew D. Cohen, Aron Fischer, Barbara L. Mullin, Jordan Engelhardt, Matthew Weiss.

Impax Oral Argument at Fifth Circuit Reveals Thorny Issues and Uncertain Outcome

USA - June 29 2020 On June 9, the United States Court of Appeals for the Fifth Circuit heard oral argument in Impax Laboratories, Inc., Etc. v. Federal Trade Commission…

Amy N. Vegari, Jake Walter-Warner.

The New Brandeis School Manifesto

USA - February 5 2020 As this blog has previously reported, new strains of thought about antitrust law are blossoming in the United States. The “New Brandeisians”…

Jake Walter-Warner.